R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, vol.66, pp.7-30, 2016.

M. Abal, M. Llauradó, A. Doll, M. Monge, E. Colas et al., Molecular determinants of invasion in endometrial cancer, Clin Transl Oncol, vol.9, pp.272-279, 2007.

E. Colas, N. Pedrola, L. Devis, T. Ertekin, I. Campoy et al., The EMT signaling pathways in endometrial carcinoma, Clin Transl Oncol, vol.14, pp.715-735, 2012.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation, Cell, vol.144, pp.646-74, 2011.

C. Francí, M. Takkunen, D. N. , A. F. Gómez, S. Rodríguez et al., Expression of SNAIL protein in tumor-stroma interface, Oncogene, vol.25, pp.5134-5178, 2006.

G. Christofori, New signals from the invasive front, Nature, vol.441, pp.444-50, 2006.

M. A. Bowen, J. Bajorath, D. 'egidio, M. Whitney, G. S. Palmer et al., Characterization of mouse ALCAM (CD166): The CD6-binding domain is conserved in different homologs and mediates cross-species binding, Eur J Immunol, vol.27, pp.1469-78, 1997.

G. W. Swart, Activated leukocyte cell adhesion molecule (CD166/ALCAM): Developmental and mechanistic aspects of cell clustering and cell migration, Eur J Cell Biol, vol.81, pp.313-334, 2002.

J. E. Skonier, M. A. Bowen, J. Emswiler, A. Aruffo, J. Bajorath et al., Recognition of diverse proteins by members of the immunoglobulin superfamily: Delineation of the receptor binding site in the human CD6 ligand ALCAM, Biochemistry, vol.35, pp.25783-90, 1996.

A. W. Zimmerman, J. M. Nelissen, S. E. Van-emst-de-vries, P. H. Willems, F. De-lange et al., Cytoskeletal restraints regulate homotypic ALCAM-mediated adhesion through PKCalpha independently of Rho-like GTPases, J Cell Sci, vol.117, pp.2841-52, 2004.

T. Riet, J. Zimmerman, A. W. Cambi, A. Joosten, B. Speller et al., Distinct kinetic and mechanical properties govern ALCAMmediated interactions as shown by single-molecule force spectroscopy, J Cell Sci, vol.120, pp.3965-76, 2007.

J. M. Nelissen, I. M. Peters, B. G. De-grooth, Y. Van-kooyk, and C. G. Figdor, Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton, Mol Biol Cell, vol.11, pp.2057-68, 2000.

C. Tudor, J. Te-riet, C. Eich, R. Harkes, N. Smisdom et al., Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton, J Biol Chem, vol.289, pp.13445-60, 2014.

T. Riet, J. Helenius, J. Strohmeyer, N. Cambi, A. Figdor et al., Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6, J Cell Sci, vol.127, pp.1595-606, 2014.

K. Thelen, T. Georg, S. Bertuch, P. Zelina, and G. E. Pollerberg, Ubiquitination and Endocytosis of Cell Adhesion Molecule DM-GRASP Regulate Its Cell Surface Presence and Affect Its Role for Axon Navigation, J Biol Chem, vol.283, pp.32792-801, 2008.

T. Piazza, E. Cha, I. Bongarzone, S. Canevari, A. Bolognesi et al., Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody, J Cell Sci, vol.118, pp.1515-1540, 2005.

O. Rosso, T. Piazza, I. Bongarzone, A. Rossello, D. Mezzanzanica et al., The ALCAM shedding by the metalloprotease ADAM17/ TACE is involved in motility of ovarian carcinoma cells, Mol Cancer Res, vol.5, pp.1246-53, 2007.

U. H. Weidle, D. Eggle, S. Klostermann, and G. W. Swart, ALCAM/ CD166: Cancer-related issues, Cancer Genomics and Proteomics, vol.7, pp.231-274, 2010.

L. C. Van-kempen, J. J. Van-den-oord, G. N. Van-muijen, U. H. Weidle, H. P. Bloemers et al., Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin

, Am J Pathol, vol.156, issue.10, pp.64943-64950, 2000.

G. Kristiansen, C. Pilarsky, C. Wissmann, C. Stephan, L. Weissbach et al., ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions, Prostate, vol.54, pp.34-43, 2003.

A. G. Hansen, T. J. Freeman, S. A. Arnold, A. Starchenko, C. R. Jones-paris et al., Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome, Cancer Res, vol.73, pp.2955-64, 2013.

J. A. King, S. F. Ofori-acquah, T. Stevens, A. B. Al-mehdi, O. Fodstad et al., Activated leukocyte cell adhesion molecule in breast cancer: Prognostic indicator, Breast Cancer Res, vol.6, pp.478-87, 2004.

G. Carbotti, A. M. Orengo, D. Mezzanzanica, M. Bagnoli, A. Brizzolara et al., Activated leukocyte cell adhesion molecule soluble form: A potential biomarker of epithelial ovarian cancer is increased in type II tumors, Int J Cancer, vol.132, pp.2597-605, 2013.

M. Van-den-brand, R. P. Takes, M. Blokpoel-deruyter, P. J. Slootweg, and L. Van-kempen, Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma

, Oral Oncol, vol.46, pp.393-401, 2010.

C. Kahlert, H. Weber, C. Mogler, F. Bergmann, P. Schirmacher et al., Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse, Br J Cancer, vol.101, pp.457-64, 2009.

M. Tachezy, K. Effenberger, H. Zander, S. Minner, F. Gebauer et al., ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

, Int J Cancer, vol.131, pp.396-405, 2012.

S. F. Ofori-acquah and J. A. King, Activated leukocyte cell adhesion molecule: A new paradox in cancer, Transl Res, vol.151, pp.122-130, 2008.

V. Kulasingam, Y. Zheng, A. Soosaipillai, A. E. Leon, M. Gion et al., Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer, Int J Cancer, vol.125, pp.9-14, 2009.

S. Chaker, L. Kashat, S. Voisin, J. Kaur, I. Kak et al., Secretome proteins as candidate biomarkers for aggressive thyroid www, oncotarget.com carcinomas. Proteomics, vol.13, pp.771-87, 2013.

M. Tachezy, H. Zander, A. H. Marx, P. R. Stahl, F. Gebauer et al., ALCAM (CD166) expression and serum levels in pancreatic cancer, PLoS One, vol.7, 2012.

L. Devis, C. P. Moiola, N. Masia, E. Martinez-garcia, M. Santacana et al., Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion and metastasis in early stage endometrioid endometrial cancer, J Pathol, vol.241, pp.475-87, 2017.

E. Colas, L. Muinelo-romay, A. , L. Llaurado, M. Monge et al., ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas, Oncogene, vol.31, pp.4778-88, 2012.

N. Pedrola, L. Devis, M. Llauradó, I. Campoy, E. Martinez-garcia et al., Nidogen 1 and Nuclear Protein 1: Novel targets of ETV5 transcription factor involved in endometrial cancer invasion, Clin Exp Metastasis, vol.32, pp.467-78, 2015.

M. Monge, E. Colas, A. Doll, M. Gonzalez, A. Gil-moreno et al., ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer, Cancer Res, vol.67, pp.6753-6762, 2007.

C. Parkes, A. Kamal, A. J. Valentijn, R. Alnafakh, S. R. Gross et al., Assessing Estrogen-Induced Proliferative Response in an Endometrial Cancer Cell Line Using a Universally Applicable Methodological Guide, Int J Gynecol Cancer, vol.28, pp.122-133, 2018.

L. Muinelo-romay, E. Colas, J. Barbazan, L. Alonso-alconada, A. et al., High-risk endometrial carcinoma profiling identifies TGF-?1 as a key factor in the initiation of tumor invasion, Mol Cancer Ther, vol.10, pp.1357-66, 2011.

P. L. Ryan, R. A. Foty, J. Kohn, and M. S. Steinberg, Tissue spreading on implantable substrates is a competitive outcome of cellcell vs. cell-substratum adhesivity, Proc Natl Acad Sci, vol.98, pp.4323-4330, 2001.

L. Alonso-alconada, N. Eritja, L. Muinelo-romay, J. Barbazan, R. Lopez-lopez et al., ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas, Carcinogenesis, vol.35, pp.2679-86, 2014.

D. Théard, M. A. Raspe, D. Kalicharan, D. Hoekstra, and S. C. Van-ijzendoorn, Formation of E-cadherin/beta-cateninbased adherens junctions in hepatocytes requires serine-10 in p27(Kip1), Mol Biol Cell, vol.19, pp.1605-1618, 2008.

T. Sugihara, Loss of Adherens Junction Protein E-Cadherin is a Biomarker of High-Grade Histology and Poor Prognosis in Endometrial Cancer, Endometrial Cancer Ann Clin Lab Res, vol.4, 2016.

J. Planagumà, M. Liljeström, A. F. Bützow, R. Virtanen, I. Reventós et al., Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma, Hum Pathol, vol.42, pp.57-67, 2011.

K. Aglund, M. Rauvala, U. Puistola, T. Ångström, T. Turpeenniemi-hujanen et al., Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage, Gynecol Oncol, vol.94, pp.699-704, 2004.

N. Karahan, M. Güney, S. Baspinar, B. Oral, N. Kapucuoglu et al., Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma, Eur J Gynaecol Oncol, vol.28, pp.184-192, 2007.

N. Montserrat, A. Mozos, D. Llobet, X. Dolcet, C. Pons et al., Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma, Hum Pathol, vol.43, pp.632-675, 2012.

Y. Tanaka, Y. Terai, H. Kawaguchi, S. Fujiwara, S. Yoo et al., Prognostic impact of EMT (epithelial-mesenchymaltransition)-related protein expression in endometrial cancer, Cancer Biol Ther, vol.14, pp.13-22, 2013.

E. Martinez-garcia, A. Lesur, L. Devis, A. R. Campos, S. Cabrera et al., Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples, Oncotarget, vol.7, pp.53102-53117, 2016.

A. Egloff, S. A. Du, L. Loomans, H. A. Starchenko, A. Su et al., Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer, Oncotarget, vol.8, pp.305-317, 2012.

L. C. Van-kempen, F. Meier, M. Egeblad, M. J. Kersten-niessen, C. Garbe et al., Truncation of activated leukocyte cell adhesion molecule: A gateway to melanoma metastasis, J Invest Dermatol, vol.122, pp.1293-301, 2004.

S. Moulik, S. Pal, J. Biswas, and A. Chatterjee, Role of ERK in Modulating MMP 2 and MMP 9 with Respect to Tumour Invasiveness in Human Cancer Cell Line MCF-7 and MDA-MB-231, J Tumor, vol.2, 2014.

M. L. Gardel, I. C. Schneider, Y. Aratyn-schaus, and C. M. Waterman, Mechanical integration of actin and adhesion dynamics in cell migration, Annu Rev Cell Dev Biol, vol.26, pp.315-348, 2010.

J. Yao, S. Xiong, K. Klos, N. Nguyen, R. Grijalva et al., Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-?1 in human breast cancer cells, Oncogene, vol.20, pp.8066-74, 2001.

P. Friedl and S. Alexander, Cancer Invasion and the Microenvironment: Plasticity and Reciprocity, Cell, vol.147, pp.992-1009, 2011.

L. Alonso-alconada, L. Muinelo-romay, K. Madissoo, A. Diaz-lopez, C. Krakstad et al., Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer, Mol Cancer, vol.13, p.223, 2014.

S. Cabrera, M. Llaurado, J. Castellvi, Y. Fernandez, A. F. Colas et al., Generation and characterization of orthotopic murine models for endometrial cancer, Clin Exp Metastasis, vol.29, pp.217-244, 2012.

N. C. Hübner, L. H. Wang, M. Kaulich, P. Descombes, I. Poser et al., Re-examination of siRNA specificity questions role of PICH and Tao1 in the spindle checkpoint and identifies Mad2 as a sensitive target for small RNAs, Chromosoma, vol.119, pp.149-65, 2010.

Y. S. Chu, W. A. Thomas, O. Eder, F. Pincet, E. Perez et al., Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42, J Cell Biol, vol.167, pp.1183-94, 2004.

S. Douezan, K. Guevorkian, R. Naouar, S. Dufour, D. Cuvelier et al., Spreading dynamics and wetting transition of cellular aggregates, Proc Natl Acad Sci U S A, vol.108, pp.7315-7335, 2011.